News & Events

You are here

In an article drafted for World Pharma Today, Novotech explains on how increasing clinical trial competition within Asia is of benefit to sponsors. 

19/07/17

노보텍, 임상시험실시지원기관노보텍SMO 설립

2017 719 호주시드니대한민국서울:  ...

29/06/17

Novotech receives ISO 9001:2015 certification

29 June 2017, Sydney, Australia: Asia Pacific specialist CRO Novotech announced today it has received ISO 9001:2015 Quality Management System certification for its corporate headquarters in Sydney, Australia.

...

19/06/17

Novotech signs central lab services agreement with Sonic Clinical Trials

19 June 2017, Sydney, Australia: Asia Pacific specialist CRO Novotech announced today it has expanded its business offering to include central lab services through a preferred partnership agreement with Sonic Clinical Trials, an...

13/06/17

Novotech Update: Five things you need to know about China’s changing clinical trial environment

Novotech Update: New policy reforms in China focus on reducing clinical trial start up times and improving site access 

China currently has one of the largest...

15/04/17

Novotech signs MOU with South Korea’s leading medical center, the Asan Medical Center

15 April 2017, Sydney, Australia and Seoul, Korea: Asia Pacific specialist CRO Novotech announced today it has signed a Memorandum of Understanding (MOU) with South Korea’s largest medical institution – The Asan Medical Center’s...

01/03/17

New Frost & Sullivan research reveals Asia as Preferred Destination for Clinical Trials

 

1 March 2017, Sydney, Australia: Frost & Sullivan today released its latest white paper, ‘Asia: Preferred Destination for Clinical Trials’, with Asia Pacific specialist CRO Novotech. Research...

27/01/17

Novotech Update: 8 reasons why China should be your next clinical trial destination

Happy Chinese New Year!
While China has long been a key powerhouse in Asia, its trajectory over the next decade is set to sky rocket. 

Here are 8 top facts you need to know about China’s growing economy and...

27/01/17

Novotech Update: 8 reasons why Australia should be your next clinical trial destination

Australia is internationally recognised for its superior clinical research and healthcare infrastructure, world-class research capabilities and highly killed researchers. All critical prerequisites for early phase clinical trials...

16/01/17

Novotech Update: Novotech and Deloitte brief biotech companies on benefits of accessing Australia’s R&D scheme

 

10 January 2017; San Francisco, California, United States: At a private event during this year’s JP Morgan conference, Novotech and Deloitte briefed international biotech companies on how to access...

30/12/16

Novotech Update: Novotech presents to Chinese biotechs on 3 key benefits of early stage clinical trials in Australia

Novotech presented to a number of biotechnology companies based at China’s SuZhou BioBay industrial...

Pages